Diplomatic World_nummer 57
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
THE CIDIC INTERNATIONAL AWARDS<br />
SOFIA 2018<br />
PRINTIVO is a young biotech company working in the<br />
field of bio-fabrication and tissue engineering. The staff<br />
developed a cutting-edge 3D-bioprinting technology and<br />
a unique bio-ink formula capable of sustaining cellular<br />
life and proliferation. Currently, they are focusing on<br />
3D-bioprinted bone and cartilage grafts for dental and<br />
orthopedic procedures. Several private clinics are involved<br />
in pilot tests and trials. The business model is a print-ondemand<br />
platform for highly customized and personalized<br />
tissue grafts. They plan to widen their portfolio to five<br />
different tissue analogs by the end of 2019. Printivo received<br />
the international CIDIC award for its capacity to become<br />
a real game changer in biomedical industry, based on new<br />
technology developed in-house, its creative innovation<br />
potential and the synergy within its interdisciplinary team.<br />
MICAR INNOVATION is a drug discovery factory. The<br />
company has found a niche where it is able to create a large<br />
societal impact by improving the quality of life through new<br />
blockbuster drug molecules for a large class of diseases.<br />
It focuses on non-clinical Proof-of-Concepts (POCs) in<br />
preclinical R&D and Hit-to-Lead (H2L) achievements in<br />
areas such as neuroscience, oncology, cardio-vascularity,<br />
dermatology, rare diseases. MICAR21 is their drug<br />
discovery platform for small molecule drug candidates.<br />
The business model is based on licensing their intellectual<br />
property to commercial partners and on the creation new<br />
spin out companies. Micar Innovation received the CIDIC<br />
award for its well-chosen positioning in a complex and long<br />
value chain, where it can create key-value contributions by<br />
delivering non-clinical POCs. The company can be qualified<br />
as a fountain of intellectual property and an IP broker for<br />
new pharma startups and big pharma industry.<br />
AMMEX, SPADEL and EUROSENSE, companies rooted<br />
in Belgium, received the international CIDIC awards for<br />
their involvement in strong commercial and collaborative<br />
activities with Bulgaria.<br />
136<br />
From left to right: Prof. Anastas Gerdjikov, Gerdjikov, Rector - Sofia University, Prof. Zhang Jinming, Executive Vice President University council – Renmin University<br />
of China, Prof. Jan Cornelis, Pro Vice Rector – Vrije Universiteit Brussel, H.E. Mrs. Maya Dobreva – Bulgarian Ambassador to Belgium. © Barbara Dietrich
Change language